Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheela Ramanathan

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Scientific Reports|April 17, 2026
Distinct plasma proteome signature at 3 months post-COVID-19 infection irrespective of post-COVID conditionMohammad Mobarak H Chowdhury, Akouavi Julite Irmine Quenum, Christine Rioux-Perreault, et al.
Oncoimmunology|July 30, 2016
NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytesGalaxia M Rodriguez, Diwakar Bobbala, Daniel Serrano, et al.
Cancers|February 11, 2023
SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 ActivationMd Gulam Musawwir Khan, Nadia Boufaied, Mehdi Yeganeh, et al.
Cytokine|February 13, 2016
Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver diseaseYuneivy Cepero-Donates, Grégory Lacraz, Farnaz Ghobadi, et al.
Iscience|March 27, 2023
NLRC5 affects diet-induced adiposity in female mice and co-regulates peroxisome proliferator-activated receptor PPARγ target genesSarah Bauer, Vanessa Aeissen, Alena M Bubeck, et al.
Frontiers in Sports and Active Living|June 15, 2026
Aptamer-based analyses of plasma proteome in individuals with post-COVID condition who underwent tailored physical activityMohammad Mobarak H Chowdhury, Marie-Noelle Fontaine, Sarah-Eve Lord, et al.
Cell Reports|December 5, 2019
Interleukin-27 Is Essential for Type 1 Diabetes Development and Sjögren Syndrome-like InflammationAshley E Ciecko, Bardees Foda, Jennifer Y Barr, et al.
Cell Reports|February 3, 2021
Interleukin-27 is essential for type 1 diabetes development and Sjögren syndrome-like inflammationAshley E Ciecko, Bardees Foda, Jennifer Y Barr, et al.
Immunotherapy Advances|June 22, 2026
NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responsesAkhil Shukla, Mohammad Moradzad, Akouavi Julite Irmine Quenum, et al.
Anatomical Record (Hoboken, N.J. : 2007)|October 5, 2022
Defects in the expression of colonic host defense factors associate with barrier dysfunction induced by a high-fat/high-cholesterol dietJennifer Valdes, Jessica Gagné-Sansfaçon, Vilcy Reyes, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Scientific Reports|April 17, 2026
Distinct plasma proteome signature at 3 months post-COVID-19 infection irrespective of post-COVID conditionMohammad Mobarak H Chowdhury, Akouavi Julite Irmine Quenum, Christine Rioux-Perreault, et al.
Oncoimmunology|July 30, 2016
NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytesGalaxia M Rodriguez, Diwakar Bobbala, Daniel Serrano, et al.
Cancers|February 11, 2023
SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 ActivationMd Gulam Musawwir Khan, Nadia Boufaied, Mehdi Yeganeh, et al.
Cytokine|February 13, 2016
Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver diseaseYuneivy Cepero-Donates, Grégory Lacraz, Farnaz Ghobadi, et al.
Iscience|March 27, 2023
NLRC5 affects diet-induced adiposity in female mice and co-regulates peroxisome proliferator-activated receptor PPARγ target genesSarah Bauer, Vanessa Aeissen, Alena M Bubeck, et al.
Frontiers in Sports and Active Living|June 15, 2026
Aptamer-based analyses of plasma proteome in individuals with post-COVID condition who underwent tailored physical activityMohammad Mobarak H Chowdhury, Marie-Noelle Fontaine, Sarah-Eve Lord, et al.
Cell Reports|December 5, 2019
Interleukin-27 Is Essential for Type 1 Diabetes Development and Sjögren Syndrome-like InflammationAshley E Ciecko, Bardees Foda, Jennifer Y Barr, et al.
Cell Reports|February 3, 2021
Interleukin-27 is essential for type 1 diabetes development and Sjögren syndrome-like inflammationAshley E Ciecko, Bardees Foda, Jennifer Y Barr, et al.
Immunotherapy Advances|June 22, 2026
NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responsesAkhil Shukla, Mohammad Moradzad, Akouavi Julite Irmine Quenum, et al.
Anatomical Record (Hoboken, N.J. : 2007)|October 5, 2022
Defects in the expression of colonic host defense factors associate with barrier dysfunction induced by a high-fat/high-cholesterol dietJennifer Valdes, Jessica Gagné-Sansfaçon, Vilcy Reyes, et al.
Pageof 9